Adoptive cell therapy with autologous tumor-infiltrating lymphocytes and high-dose interleukin-2 for metastatic melanoma: The surgeon's perspective

By                    

Experimental and Therapeutic Medicine, Vol. 3, Iss. 5, 2012-01 ,pp. : 898-902

Spandidos Publications

Access to resources Recommend Favorite

Subcutaneous Recombinant Interleukin-2 Plus Chemotherapy with Cisplatin and Dacarbazine in Metastatic Melanoma

By Guida M.   Latorre A.   Mastria A.   De Lena M.  

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 730-733

Elsevier

Access to resources Recommend Favorite

Phenotypic and Functional Characterisation of Tumour-infiltrating Lymphocytes Derived from Thyroid Tumours

By R.S. L.   Schlumberger M.   Caillou B.   Pages F.   Fridman W.H.   Tartour E.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1233-1239

Elsevier

Access to resources Recommend Favorite

Tumour-associated macrophages are related to progression in patients with metastatic melanoma following interleukin-2 based immunotherapy

By Hansen Bettina Dencker   Schmidt Henrik   von der Maase Hans   Sjoegren Pia   Agger Ralf   Hokland Marianne  

Acta Oncologica, Vol. 45, Iss. 4, 2006-06 ,pp. : 400-405

Informa Healthcare

Access to resources Recommend Favorite

Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma

By Khammari Amir   Nguyen Jean-Michel   Pandolfino Marie   Quereux Gaëlle   Brocard Anabelle   Bercegeay Sylvain   Cassidanius Alain   Lemarre Philippe   Volteau Christelle   Labarrière Nathalie   Jotereau Francine   Dréno Brigitte  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 11, 2007-11 ,pp. : 1853-1860

Springer Publishing Company

Access to resources Recommend Favorite